Back
Provident Bancorp Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
55
PVBC
Provident Bancorp
Last Price:
9.83
Seasonality Move:
-0.02%
Sell
49
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
43.06
Seasonality Move:
-11.02%
Buy
55
Provident Bancorp (PVBC)
is a Buy
Is Provident Bancorp a Buy, Sell or Hold?
- The current Provident Bancorp [PVBC] share price is $9.67. The Score for PVBC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PVBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.30. The Score for CRBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PVBC Stock Price Chart
What is Provident Bancorp's stock price today?
-
The Provident Bancorp share price today is $9.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PVBC is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $44.30
The current trend is moderately bearish and CRBP is experiencing slight selling pressure.
PVBC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 51.72 | Buy |
| Chaikin Money Flow: | -23104 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.39 - 9.91) | Buy |
| Bollinger Bands (100): | (8.72 - 10.04) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 49.14 | Sell |
| Chaikin Money Flow: | -68505 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.41 - 48.51) | Sell |
| Bollinger Bands (100): | (30.43 - 45.69) | Buy |
PVBC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.74 | Sell |
| 20-day SMA: | 9.72 | Sell |
| 50-day SMA: | 9.27 | Buy |
| 200-day SMA: | 9.63 | Buy |
| 8-day EMA: | 9.74 | Sell |
| 20-day EMA: | 9.68 | Sell |
| 50-day EMA: | 9.49 | Buy |
| 200-day EMA: | 9.51 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.47 | Sell |
| 20-day SMA: | 45.57 | Sell |
| 50-day SMA: | 42.55 | Buy |
| 200-day SMA: | 22.33 | Buy |
| 8-day EMA: | 44.69 | Sell |
| 20-day EMA: | 45.06 | Sell |
| 50-day EMA: | 42.58 | Buy |
| 200-day EMA: | 27.79 | Buy |
Provident Bancorp Earnings Growth & PVBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.03 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
Provident Bancorp Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||